Mounting evidence points to the soluble oligomers of amyloid β (Aβ) peptide as important neurotoxic species in Alzheimer's disease, causing synaptic dysfunction and neuronal injury, and finally leading to neuronal death. The mechanism of the Aβ peptide self-assembly is still under debate. Here, Aβ1-40 peptide oligomers were studied using mass spectrometry combined with ion mobility spectrometry, which allowed separation of the signals of numerous oligomers and measurement of their collisional cross-section values (Ω). For several oligomers, at least two different species of different Ω values were detected, indicating the presence of at least two families of conformers: compact and extended. The obtained results are rationalized by a set of...
The formation of aggregates of the amyloidogenic peptide β-amyloid (Aβ), termed oligomers, is centra...
Oligomeric forms of the Aβ peptide represent the most probable neurotoxic agent in Alzheimer's disea...
Although most cases of Alzheimer's disease (AD) are sporadic, ∼5% of cases are genetic in origin. Th...
Oligomers formed by amyloid beta peptide (Aβ) are widely believed to be the main neurotoxic agent in...
Correct folding of proteins is essential for maintaining a functional living cell. Misfolding and ag...
Oligomers of Aβ peptide are implicated as the most probable causative agent in Alzheimer’s disease. ...
In recent years, small protein oligomers have been implicated in the aetiology of a number of import...
The mechanisms behind the Amyloid-β (Aβ) peptide neurotoxicity in Alzheimer's disease are intensely ...
Since its discovery, amyloid-β (Aβ) has been the principal target of investigation of in Alzheimer's...
The formation of oligomers of the amyloid-β peptide plays a key role in the onset of Alzheimer's dis...
Amyloid β-protein (Aβ) has been correlated with Alzheimer’s disease (AD) which is the most common fo...
Oligomeric forms of the Aβ peptide represent the most probable neurotoxic agent in Alzheimer’s disea...
The amyloid-β (Aβ) peptide is associated with the development of Alzheimer’s disease and is known to...
Oligomeric species populated during the aggregation of the Aβ42 peptide have been identified as pote...
Amyloidogenic peptide oligomers are responsible for a variety of neurodegenerative disorders such as...
The formation of aggregates of the amyloidogenic peptide β-amyloid (Aβ), termed oligomers, is centra...
Oligomeric forms of the Aβ peptide represent the most probable neurotoxic agent in Alzheimer's disea...
Although most cases of Alzheimer's disease (AD) are sporadic, ∼5% of cases are genetic in origin. Th...
Oligomers formed by amyloid beta peptide (Aβ) are widely believed to be the main neurotoxic agent in...
Correct folding of proteins is essential for maintaining a functional living cell. Misfolding and ag...
Oligomers of Aβ peptide are implicated as the most probable causative agent in Alzheimer’s disease. ...
In recent years, small protein oligomers have been implicated in the aetiology of a number of import...
The mechanisms behind the Amyloid-β (Aβ) peptide neurotoxicity in Alzheimer's disease are intensely ...
Since its discovery, amyloid-β (Aβ) has been the principal target of investigation of in Alzheimer's...
The formation of oligomers of the amyloid-β peptide plays a key role in the onset of Alzheimer's dis...
Amyloid β-protein (Aβ) has been correlated with Alzheimer’s disease (AD) which is the most common fo...
Oligomeric forms of the Aβ peptide represent the most probable neurotoxic agent in Alzheimer’s disea...
The amyloid-β (Aβ) peptide is associated with the development of Alzheimer’s disease and is known to...
Oligomeric species populated during the aggregation of the Aβ42 peptide have been identified as pote...
Amyloidogenic peptide oligomers are responsible for a variety of neurodegenerative disorders such as...
The formation of aggregates of the amyloidogenic peptide β-amyloid (Aβ), termed oligomers, is centra...
Oligomeric forms of the Aβ peptide represent the most probable neurotoxic agent in Alzheimer's disea...
Although most cases of Alzheimer's disease (AD) are sporadic, ∼5% of cases are genetic in origin. Th...